Late sodium current in human, canine and guinea pig ventricular myocardium

https://doi.org/10.1016/j.yjmcc.2019.12.015Get rights and content

Highlights

  • Marked interspecies differences exist in the profile of cardiac INa-late.

  • In human and dog INa-late decreases, while in guinea pig increases during the AP.

  • This is a consequence of the slower inactivation of INa-late in guinea pig.

  • The ATX-II induced current is different from the native INa-late in dog.

  • Dog ventricular myocyte is the best model for studying human INa-late.

Abstract

Although late sodium current (INa-late) has long been known to contribute to plateau formation of mammalian cardiac action potentials, lately it was considered as possible target for antiarrhythmic drugs. However, many aspects of this current are still poorly understood. The present work was designed to study the true profile of INa-late in canine and guinea pig ventricular cells and compare them to INa-late recorded in undiseased human hearts. INa-late was defined as a tetrodotoxin-sensitive current, recorded under action potential voltage clamp conditions using either canonic- or self-action potentials as command signals. Under action potential voltage clamp conditions the amplitude of canine and human INa-late monotonically decreased during the plateau (decrescendo-profile), in contrast to guinea pig, where its amplitude increased during the plateau (crescendo profile). The decrescendo-profile of canine INa-late could not be converted to a crescendo-morphology by application of ramp-like command voltages or command action potentials recorded from guinea pig cells. Conventional voltage clamp experiments revealed that the crescendo INa-late profile in guinea pig was due to the slower decay of INa-late in this species. When action potentials were recorded from multicellular ventricular preparations with sharp microelectrode, action potentials were shortened by tetrodotoxin, which effect was the largest in human, while smaller in canine, and the smallest in guinea pig preparations. It is concluded that important interspecies differences exist in the behavior of INa-late. At present canine myocytes seem to represent the best model of human ventricular cells regarding the properties of INa-late. These results should be taken into account when pharmacological studies with INa-late are interpreted and extrapolated to human. Accordingly, canine ventricular tissues or myocytes are suggested for pharmacological studies with INa-late inhibitors or modifiers. Incorporation of present data to human action potential models may yield a better understanding of the role of INa-late in action potential morphology, arrhythmogenesis, and intracellular calcium dynamics.

Introduction

Although late Na+ current (INa-late) is an important current flowing during the action potential (AP) plateau in mammalian cardiomyocytes with physiological and pathological significance recognized long ago [[1], [2], [3]], its pathophysiological role in LQT3 [4] and heart failure [[5], [6], [7], [8]] has been emphasized only in the last decades. INa-late - as an inward current - contributes to plateau formation and is responsible for largely half of the transmembrane Na+ entry [[9], [10], [11]]. As a consequence, the elevation of INa-late results in increased arrhythmia propensity (e.g. in heart failure) including prolongation of the action potential duration (APD), increased inhomogeneity of repolarization and occurrence of early as well as delayed afterdepolarizations [5,[12], [13], [14]]. Therefore, as a new concept, intensive efforts were made recently to develop selective inhibitors of INa-late [9,15,16].

Initially INa-late was believed to be a consequence of the overlapping steady-state activation and inactivation functions of the Na+ current (window Na+ current) [17], now it is better explained by the slow inactivation kinetics of a small fraction of cardiac Na+ channels (mode-II gating, bursting and late openings) [4,6]. In spite of its relative importance, many aspects of INa-late are still poorly understood. In contrast to the detailed data obtained in rabbit [18], guinea pig [19] and porcine [20] myocytes, we have only a limited number of recordings of native human and canine INa-late, since these experiments were typically performed using conventional voltage clamp arrangements and many of them at room temperature [7,8,[21], [22], [23]]. Self action potential voltage clamp measurements, delivering the cell's own AP as a command signal, are not available in the literature either for canine or human ventricular cardiomyocytes. Since canine ventricular cells are believed to be a good model for human ventricular myocytes in general regarding their cellular electrophysiological properties [[24], [25], [26]], our goal was to monitor and compare the profiles of INa-late in ventricular cells obtained from canine, guinea pig and undiseased human hearts. The rationale of our work is given by the very limited availibilty of undiseased human ventricular tissues for experimental purposes, and our results show that canine myocytes - but not guinea pig cells - are reasonably suitable preparations for studying the properties of human INa-late.

Section snippets

Preparations

Adult mongrel dogs of either sex (35 animals) were anesthetized with intramuscular injections of 10 mg/kg ketamine hydrochloride (Calypsol, Richter Gedeon, Hungary) + 1 mg/kg xylazine hydrochloride (Sedaxylan, Eurovet Animal Health BV, The Netherlands) according to a protocol approved by the local Animal Care Committee (license No: 9/2015/DEMÁB). All animal procedures conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific

Results

Primarily the optimal TTX concentration for dissection INa-late in canine ventricular myocytes had to be determined in order to find a TTX concentration that is suitable to excise a sufficiently large portion of INa-late allowing visualization of the true profile of the current. Representative records presented in Fig. 1.A indicate that the effect of TTX tends to saturate at the concentration of 10 μM. Based on the concentration-response curves obtained by fitting these data to the Hill

Discussion and conclusions

This is the first study to demonstrate the profiles of human and canine ventricular INa-late under self APVC conditions. From this perspective our results are in line with those of Murphy et al. [23] who have shown the profile of canine INa-late using canonic APs. Regarding undiseased human ventricular cells, this is the first report using the APVC technique. Our most important finding was to demonstrate that canine myocytes can be used as a reasonably good model to study human INa-late - in

Funding

This work was funded by the National Research Development and Innovation Office (NKFIH-K115397 to P.P.N, NKFIH-PD120794 and NKFIH-FK128116 to B.H. NKFIH-PD125402 and NKFIH-FK129117 to N.N., and NKFIH-K119992 to A.V.). Further support was obtained from the GINOP-2.3.2.-15-2016-00040 and EFOP-3.6.2-16-2017-00006 projects, which are co-financed by the European Union and the European Regional Development Fund. The work was also supported by the Hungarian Academy of Sciences (János Bolyai Research

Declaration of Competing Interest

None declared.

References (43)

  • E. Carmeliet

    Slow inactivation of sodium current and voltage-dependent block by tetrodotoxin in rabbit cardiac Purkinje fibers

    Biomed. Biochim. Acta

    (1986)
  • K.R. Chadda et al.

    Sodium channel biophysics, late sodium current and genetic arrhythmic syndromes

    Pflügers Arch.

    (2017)
  • B. Horvath et al.

    The late sodium current in heart failure: pathophysiology and clinical relevance

    ESC Heart Failure

    (2014)
  • V.A. Maltsev et al.

    Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability

    Eur. J. Heart Fail.

    (2007)
  • Y. Song et al.

    Basal late sodium current is a significant contributor to the duration of action potential of guinea pig ventricular myocytes

    Physiol. Rep.

    (2017)
  • V.A. Maltsev et al.

    A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes

    Cardiovasc. Res.

    (2006)
  • D. Noble et al.

    Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload

    Heart

    (2006)
  • A. Zaza et al.

    The late Na+ current - origin and pathophysiological relevance

    Cardiovasc. Drugs Ther.

    (2013)
  • J.C. Shyrock et al.

    The antiarrhythmogenic consequences of increasing late INa in the cardiomyocyte

    Cardiovasc. Res.

    (2013)
  • S. Yu et al.

    Late sodium current associated cardiac electrophysiological and mechanical dysfunction

    Pflügers Arch.

    (2018)
  • C. Antzelevitch et al.

    The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis

    J. Cardiovasc. Electrophysiol.

    (2006)
  • Cited by (21)

    • Ion current profiles in canine ventricular myocytes obtained by the “onion peeling” technique

      2021, Journal of Molecular and Cellular Cardiology
      Citation Excerpt :

      This problem was resolved by the introduction of the action potential voltage clamp technique (APVC, first applied by Fischmeister in 1984 [1]), which is based essentially on pharmacological current dissection using the original AP waveform of the cell as a command signal. The APVC technique was successfully applied in a variety of mammalian cardiac cells, including rats [2], pigs [3,4], rabbits [2,3,5,6,7], guinea pigs [8,9,10,11,12,13,14,15], dogs [16,17,18,19,20] and humans [21,22,23,24]. Despite the abundance of APVC data, little attempt was made to study the correlation of various ion current densities within the same cell.

    • Mitochondrial Ca<sup>2+</sup>, redox environment and ROS emission in heart failure: Two sides of the same coin?

      2021, Journal of Molecular and Cellular Cardiology
      Citation Excerpt :

      Two small clinical trials with eleclazine and ranolazine, however, failed to prove the efficacy of these treatments and ended prematurely [146,147] although these results should be interpreted with caution because of the small numbers of patients studied. For a current detailed report on the role and properties of INaL we refer the readers to [148]. The cardiac NHE has been recognized for many years as a central regulator of intracellular pH (pHi) and Na+i [133,134].

    View all citing articles on Scopus
    View full text